Strata Critical Medical (SRTA) Non-Current Assets (2019 - 2026)

Strata Critical Medical has disclosed Non-Current Assets across 8 years of filings, most recently posting $203.5 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 107.12% year-over-year to $203.5 million; the TTM figure through Mar 2026 stood at $716.8 million (up 77.96% YoY), while the FY2025 annual figure was $199.3 million, up 107.73% from the prior year.
• Non-Current Assets grew to $203.5 million in Q1 2026, from $199.3 million in the prior quarter.
• Over the last five years, Non-Current Assets for SRTA reached as high as $212.6 million in Q3 2025 and fell as low as $41.4 million in Q1 2022.
• The 5-year median for Non-Current Assets is $101.4 million (2025), against an average of $113.3 million.
• The widest YoY moves for Non-Current Assets: up 1243.92% in 2022, down 85.13% in 2022.
• A 5-year view of Non-Current Assets shows it stood at $106.9 million in 2022, then decreased by 17.05% to $88.7 million in 2023, then grew by 8.18% to $95.9 million in 2024, then surged by 107.73% to $199.3 million in 2025, then rose by 2.1% to $203.5 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $203.5 million, $199.3 million, and $212.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.